GDF-8 Inhibitors

Common GDF-8 Inhibitors include, but are not limited to (-)Epicatechin CAS 490-46-0, GW501516 CAS 317318-70-0, Cyclosporin A CAS 59865-13-3, Nutlin-3 CAS 548472-68-0 and Prostaglandin F2α CAS 551-11-1.

GDF-8, more commonly known as Myostatin, is a member of the TGF-β superfamily of proteins. It is a secreted growth differentiation factor that has been identified to play a pivotal role in the regulation of skeletal muscle mass. Myostatin acts as a negative regulator of muscle growth; in other words, it suppresses the development and regeneration of muscle tissue. This function has been demonstrated in various animal models where the absence or reduced levels of Myostatin led to significant hypertrophy or increased muscle mass. The protein achieves its regulatory effects by binding to the activin type II receptor, disrupting the downstream signaling essential for muscle cell proliferation and differentiation.

GDF-8 inhibitors, or Myostatin inhibitors, comprise a class of molecules that specifically target and impede the activity of Myostatin. The inhibition of Myostatin can result in enhanced muscle growth, given its natural role as a suppressor. These inhibitors might function by directly binding to Myostatin, preventing it from interacting with its receptor, or by interfering with its production or secretion pathways. Additionally, some GDF-8 inhibitors could function by blocking the receptor's interaction sites, rendering Myostatin unable to deliver its suppressive signal. The study of GDF-8 inhibitors offers crucial insights into the intricate molecular mechanisms underlying muscle growth regulation. By understanding the nuances of these inhibitors, researchers can gain a clearer picture of Myostatin's role in muscle physiology and the broader implications of modulating its activity at the molecular level.